Celltrion Pharm Inc
KOSDAQ:068760
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
C
|
Celltrion Pharm Inc
KOSDAQ:068760
|
KR |
|
CEZ as
PSE:CEZ
|
CZ |
|
A
|
Accenture PLC
F:CSA
|
IE |
|
W
|
Wendel SE
DUS:WIS
|
FR |
|
C
|
Cronos Group Inc
XMUN:7CI
|
CA |
|
H
|
HEICO Corp
F:HC1
|
US |
|
H
|
Helen of Troy Ltd
XMUN:HT2
|
BM |
|
Asia Sejahtera Mina Tbk PT
IDX:AGAR
|
ID |
|
Datametrex AI Ltd
F:D4G
|
CA |
|
P
|
PT Adaro Andalan Indonesia Tbk
IDX:AADI
|
ID |
Intrinsic Value
Is Celltrion Pharm Inc undervalued or overvalued?
See the intrinsic value estimate for Celltrion Pharm Inc and find out whether today’s valuation is cheap or expensive by its own historical standards.
Do our valuations actually work? See backtest results .
Fundamental Analysis
What Celltrion Pharm Does
Celltrion Pharm Inc. makes prescription medicines and sells them mainly in South Korea. Its product line includes generic drugs and hospital-focused treatments such as injectables and other branded medicines used for conditions like ulcers, allergies, infections, and chronic diseases. The company earns money by manufacturing these drugs and selling them through pharmacies, hospitals, and drug distributors.
- Headquarters
- Korea KR
- Employees
- 243
- IPO date
- Feb 3, 2006
Revenue & Expenses Breakdown
Celltrion Pharm Inc
Earnings Waterfall
Celltrion Pharm Inc
The intrinsic value for Celltrion Pharm Inc (068760) under the Base Case is hidden KRW.
Compared with the current market price of 36 650 KRW, the stock appears hidden.